Skip to content

Provider profile

Samsung Biologics.

Biologics CDMOs

Samsung Biologics documents cell line development, process, formulation and analytical development, and cGMP drug substance and aseptic fill-finish drug product manufacturing for monoclonal antibodies, recombinant proteins, mRNA and ADCs, from IND-stage to commercial supply. It lists manufacturing campuses in Songdo (Incheon, South Korea) and Rockville, Maryland, and offices in the US, Tokyo and Amsterdam.

Website
samsungbiologics.com (opens in a new tab)
Sources reviewed
November 3, 2026 · Source pages re-checked within 4 months
First published
November 3, 2026

This profile summarizes what public sources state about the provider, mostly its own website. It is not an audit, qualification or endorsement by ArgusBio. Confirm capabilities directly with the provider before contracting.

Services and capabilities

Services and capabilities

  • Analytical development and QC testing1,3
  • Bioconjugation (ADC)7Conjugation performed at the dedicated ADC facility in Songdo
  • Cell line development1,4
  • Formulation development12
  • GMP drug product manufacturing1,5,6
  • GMP drug substance manufacturing5
  • Highly potent APIs7Stated for the dedicated ADC facility in Songdo
  • Lyophilization1,6Stated as part of aseptic fill-finish (drug product) services
  • Process development1,2
  • Stability studies8
  • Technology transfer5

Platforms and methods

  • Mammalian cell culture9
  • Single-use bioreactors9,10Single-use and stainless steel bioreactors; 50 L and 200 L single-use for non-GMP/development manufacturing

Drug substance / drug product

  • Drug product1,5
  • Drug substance5,11

Development experience

Development experience

Development stage

  • Commercial5,9
  • Phase 12
  • Preclinical10Non-GMP toxicology material generation

Modality

  • Antibody-drug conjugates7,9
  • Monoclonal antibodies5,9
  • mRNA and nucleic acids9Listed among drug substance manufacturing services
  • Recombinant proteins9
  • Small molecules1,6Small molecules stated only for aseptic fill-finish (drug product)

Locations

Locations

  • Tokyo, Japan · Office13Regional office
  • Schiphol, Netherlands · Office13Listed by the company as its Amsterdam (Europe) office
  • Incheon, South Korea · Manufacturing site13Songdo campuses: Bio Campus I (Plants 1-4) and Bio Campus II (Plant 5) for drug substance, plus the dedicated ADC facility; the site footer gives 300, Songdobio-daero, Yeonsu-gu, Incheon as the company address
  • Boston, United States · Office13Sales office
  • Ridgefield Park, United States · Office13Samsung Biologics America sales office (New Jersey)
  • Rockville, United States · Manufacturing site11Drug substance manufacturing (60 kL, stainless steel)

Quality and regulatory

Quality and regulatory

The provider’s own materials state that it works to, or holds, the following. ArgusBio has not inspected or audited these claims.

  • GMP / cGMP5

Unknowns and questions to ask

Unknowns and questions to ask

Public sources rarely establish what matters most for a specific project. Confirm directly:

  • Available capacity, slot timing and scale for your next campaign
  • Recent experience with your specific modality and expression system or chemistry
  • Regulatory inspection history of the specific site that would manufacture your product
  • Technology-transfer approach, timeline and who owns the resulting process knowledge
  • Analytical and QC release testing done in-house versus subcontracted
  • Quality agreement terms, batch-failure responsibility and change-order mechanics

Choosing a CDMO: a practical guide

Evidence and sources

Evidence and sources

  1. 1Our Services | Samsung Biologics (opens in a new tab)Samsung Biologics · Provider website · retrieved November 3, 2026 · last checked November 3, 2026
  2. 2Biologics Development Services | CDMO Solutions (opens in a new tab)Samsung Biologics · Provider website · retrieved November 3, 2026 · last checked November 3, 2026
  3. 3Analytical Testing Services | Samsung Biologics (opens in a new tab)Samsung Biologics · Provider website · retrieved November 3, 2026 · last checked November 3, 2026
  4. 4Cell Line Development Services | Samsung Biologics (opens in a new tab)Samsung Biologics · Provider website · retrieved November 3, 2026 · last checked November 3, 2026
  5. 5Biologics Development Services | CDMO Solution | Samsung Biologics (opens in a new tab)Samsung Biologics · Provider website · retrieved November 3, 2026 · last checked November 3, 2026
  6. 6Drug Product Manufacturing | Aseptic Fill Finish CDMO (opens in a new tab)Samsung Biologics · Provider website · retrieved November 3, 2026 · last checked November 3, 2026
  7. 7Samsung Biologics | Global CDMO for End-to-End Biopharma Services (opens in a new tab)Samsung Biologics · Provider website · retrieved November 3, 2026 · last checked November 3, 2026
  8. 8Analytical Development Services | Samsung Biologics (opens in a new tab)Samsung Biologics · Provider website · retrieved November 3, 2026 · last checked November 3, 2026
  9. 9Drug Substance Manufacturing Services | Samsung Biologics (opens in a new tab)Samsung Biologics · Provider website · retrieved November 3, 2026 · last checked November 3, 2026
  10. 10Non-GMP & CGMP Manufacturing Services | Samsung Biologics (opens in a new tab)Samsung Biologics · Provider website · retrieved November 3, 2026 · last checked November 3, 2026
  11. 11Rockville Campus | Samsung Biologics (opens in a new tab)Samsung Biologics · Provider website · retrieved November 3, 2026 · last checked November 3, 2026
  12. 12Process Development Services | Samsung Biologics (opens in a new tab)Samsung Biologics · Provider website · retrieved November 3, 2026 · last checked November 3, 2026
  13. 13Samsung Biologics | Global CDMO for End-to-End Biopharma Services (opens in a new tab)Samsung Biologics · Provider website · retrieved November 3, 2026 · last checked November 3, 2026

“Last checked” means we confirmed the page was still available and still contained the cited statement. It does not mean ArgusBio verified the provider or its capabilities.

Something out of date or wrong? Request a correction. Corrections are reviewed against public sources before publication.

Contact

Contact

Contact the provider directly through its public contact page (opens in a new tab). ArgusBio does not forward inquiries to providers and does not receive referral fees.

Compare with other biologics cdmos providers

ArgusBio sourcing

Need help evaluating this provider or comparing alternatives.

Discuss your sourcing need with ArgusBio. We can help define the scope, identify comparable alternatives and organize proposals so the decision stays yours.

Discuss a sourcing need

We work for the biotech, not the vendor. Vendors do not pay for inclusion or placement.